Cargando…
CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma
Activating alterations in PIK3CA, the gene coding for the catalytic subunit of phosphoinositide-3-kinase (PI3K), are prevalent in head and neck squamous cell carcinoma (HNSCC) and thought to be one of the main drivers of these tumors. However, early clinical trials on PI3K inhibitors (PI3Ki) have be...
Autores principales: | Remer, Eric, Badarni, Mai, Hikri, Elad, Dayan, Avraham, Levi, Lirit, Popovtzer, Aron, Iraqi, Muhammed, Porgador, Angel, Joshua, Ben-Zion, Bachar, Gideon, Elkabets, Moshe, Scaltriti, Maurizio, Mizrachi, Aviram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601167/ https://www.ncbi.nlm.nih.gov/pubmed/33036331 http://dx.doi.org/10.3390/jcm9103214 |
Ejemplares similares
-
Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma
por: Levi, Lirit, et al.
Publicado: (2023) -
Gene Expression and Drug Sensitivity Analysis of Mitochondrial Chaperones Reveals That HSPD1 and TRAP1 Expression Correlates with Sensitivity to Inhibitors of DNA Replication and Mitosis
por: Badarni, Mai, et al.
Publicado: (2023) -
Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy
por: Ghosh, Susmita, et al.
Publicado: (2019) -
Is the Risk to Develop Osteoradionecrosis of the Jaws Following IMRT for Head and Neck Cancer Related to Co-Factors?
por: Rosenfeld, Eli, et al.
Publicado: (2021) -
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs
por: Iraqi, Muhammed, et al.
Publicado: (2022)